Keywords: Crossmatch; Allocation; Kidney transplantation; HLA; Sensitization;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: cPRA; calculated panel reactive antibody; CXM; crossmatch; FCXM; flow cytometric crossmatch; KAS; revised kidney allocation system; MCS; mean channel shift; MFI; mean fluorescence intensity; PRA; panel reactive antibody; SPI; solid phase immunoassay; VCXM
Keywords: Abs; antibodies; ATG; antithymocyte globulin; BSX; basiliximab; DSA; donor-specific antibody; DTT; dithiothreitol; ECZ; eculizumab; FC; flow cytometry; HLA; human leukocyte antigen; IVIg; intravenous immunoglobulin; LCT; lymphocytotoxicity; MoAbs; monoclo
Donor-specific HLA antibodies in predicting crossmatch outcome: Comparison of three different laboratory techniques
Keywords: Crossmatch; Donor-specific antibodies; HLA antibodies; Kidney transplantation; Solid-phase assay; AUC; area under curve; CDC; Complement-dependent cytotoxicity; CDCXM; Complement-dependent cytotoxicity crossmatch; DSA; donor specific antibodies; DTT; dith
Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies
Keywords: Kidney transplant; Deceased donor; Acute rejection; Donor-specific antibodies; HLA-antibodies; %PRA; panel reactive antibody percentage; AMR; antibody mediated rejection; ACR; acute cellular rejection; AR; acute rejection; CDC; complement-dependent cytoto
Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols
Keywords: 3SD; 3 standard deviations; CDC; complement-dependent cytotoxicity; DSA; donor-specific HLA antibodies; FCXM; flow cytometry crossmatch; FWB; flow wash buffer; HLA; human leukocyte antigen; MCF; median channel fluorescence; MCFS; median channel fluorescen
The management of antibodies in heart transplantation: An ISHLT consensus document
Keywords: heart transplantation; antibodies; HLA; sensitization; crossmatch; antibody-mediated rejection; non-HLA antibodies;
Fatal accelerated rejection with a prominent natural killer cell infiltrate in a heart transplant recipient with peripartum cardiomyopathy
Keywords: Transplantation; Rejection; NK cells; ACR; acute cellular rejection; AMR; antibody-mediated rejection; CMV; cytomegalovirus; CPRA; calculated panel reactive antibody; DSA; donor specific antibody; Ig; immunoglobulins; ISHLT; International Society for Hear
HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Keywords: cPRA; calculated panel reactive antibody; CDC; complement dependent cytotoxicity; XM; crossmatch; DD; deceased donor; DSA; donor specific antibodies; KAS; kidney allocation system; MFI; mean fluorescence intensity; PCR; polymerase chain reaction; RT-PCR;
CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients
Keywords: CPRA; HLA antibodies; Sensitization; Crossmatch; Kidney transplant
MEDICINA TRANSFUSIONAL EN EL SIGLO XXI
Keywords: Transfusión; abastecimiento de sangre; componentes; glóbulos rojos (GRs); plaquetas; plasma; centro de sangre; unidad de medicina transfusional; reacciones adversas; hemovigilancia; VIH; compatibilidad; crossmatch; seguridad.Transfusion; blood supply; com
Nothing's perfect: The art of defining HLA-specific antibodies
Keywords: HLA antibody; Solid phase assay; Clinical relevance; Single antigen beads; Crossmatch
The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients
Keywords: CDCXM; complement-dependent cytotoxicity crossmatch; DSA; donor-specific antibodies; DTT; dithiothreitol; EDTA; ethylene diamine tetracetic acid; FCXM; flow cytometry crossmatch; MCS; mean fluorescence channel shift; MFI; mean fluorescence intensity; SAFB
Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation
Keywords: pediatric; heart transplantation; allosensitization; crossmatch;
Pediatric Heart Transplantation for Congenital and Restrictive Cardiomyopathy
Keywords: ABOi; ABO incompatible; AMR; Antibody-mediated rejection; CDC; Complement-dependent cytotoxicity; CHD; congenital heart disease; CPB; cardiopulmonary bypass; CRF; calculated reaction frequency; DCM; dilatated cardiomyopathy; DSA; donor-specific antibody;
High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation
Keywords: Flow cytometry; Crossmatch; T cell; Living donor kidney transplantation; Biotin-streptavidin amplifier system
The role of positive flow cytometry crossmatch in late renal allograft loss
Keywords: Crossmatch; Flow cytometry crossmatch; Graft failure; Kidney transplant; Registries
Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study
Keywords: Crossmatch; Kidney transplantation; Heart transplantation; Liver transplantation; Graft outcome
Clinical significance of anti-HLA antibodies detected by Luminex®: Enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools
Keywords: HLA antibodies; Luminex®; Crossmatch; Renal transplantation; Monitoring
Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay
Keywords: Solid phase; Donor specific; Luminex; Alloantibody; Crossmatch
Positive B-cell only flow cytometric crossmatch: Implications for renal transplantation
Keywords: Kidney transplant; Crossmatch; Antibodies; Flow cytometry
Flow-cytometric screening of platelet antibodies with previously frozen cells
Keywords: Crossmatch; Platelets; Refractoriness; Antibodies; Flow-cytometry; Frozen cells;
Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing
Keywords: Transplant; Histocompatibility; Crossmatch; Antibodies; Interference; PRA;
Desensitization protocols improving access and outcome in transplantation
Keywords: ABO incompatible transplantation; Desensitization; Double filtration plasmapheresis; HLA-specific antibody; Intravenous immunoglobulin (IVIg); Plasmapheresis; Sensitization; Transplantation; ABO-DSA; antibody to donor ABO antigens; ABOi; ABO incompatible;